NVO · NYSE, OTC · CIK 0000353278

NOVO NORDISK A S

NOVO NORDISK A S’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 26, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of DKK 309.1B and net income of DKK 102.4B, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
DKK 309.1B
Net income, FY2025
DKK 102.4B
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
NOVO NORDISK A S
Tickers
NVO, NONOF
SEC Central Index Key (CIK)
0000353278
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
BAGSVAERD DENMARK, Denmark
State or country of incorporation
—
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#87 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from NOVO NORDISK A S’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in DKK; the fiscal year is named for the calendar year in which it ends.

Revenue
DKK 140.8BFY2021DKK 177.0BFY2022DKK 232.3BFY2023DKK 290.4BFY2024DKK 309.1BFY2025
Net income
DKK 47.8BFY2021DKK 55.5BFY2022DKK 83.7BFY2023DKK 101.0BFY2024DKK 102.4BFY2025
NVO annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
RevenueDKK 140.8BDKK 177.0BDKK 232.3BDKK 290.4BDKK 309.1B
Net incomeDKK 47.8BDKK 55.5BDKK 83.7BDKK 101.0BDKK 102.4B
Diluted EPSDKK 10.37DKK 12.22DKK 18.62DKK 22.63DKK 23.03
Total assetsDKK 194.5BDKK 241.3BDKK 314.5BDKK 465.6BDKK 542.9B
Cash and equivalentsDKK 10.7BDKK 12.7BDKK 14.4BDKK 15.7BDKK 26.5B

XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

NVO latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 4, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 26, 20266-KReport of a foreign private issuer· period Oct 26, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about NOVO NORDISK A S, by form type:

6-K ×3611-K ×2SCHEDULE 13G/A ×1SD ×1
NVO recent filings
FiledFormWhat it isOriginal
Oct 26, 20266-KReport of a foreign private issuer· period Oct 26, 2026Document · Index
Oct 19, 20266-KReport of a foreign private issuer· period Oct 19, 2026Document · Index
Oct 13, 20266-KReport of a foreign private issuer· period Oct 12, 2023Document · Index
Oct 6, 20266-KReport of a foreign private issuer· period Oct 5, 2026Document · Index
Oct 5, 20266-KReport of a foreign private issuer· period Oct 2, 2026Document · Index
Sep 28, 20266-KReport of a foreign private issuer· period Sep 28, 2026Document · Index
Sep 21, 20266-KReport of a foreign private issuer· period Sep 21, 2026Document · Index
Sep 17, 20266-KReport of a foreign private issuer· period Sep 17, 2026Document · Index
Sep 15, 20266-KReport of a foreign private issuer· period Sep 14, 2026Document · Index
Sep 9, 20266-KReport of a foreign private issuer· period Sep 7, 2026Document · Index
Aug 31, 20266-KReport of a foreign private issuer· period Aug 31, 2026Document · Index
Aug 24, 20266-KReport of a foreign private issuer· period Aug 24, 2026Document · Index
Aug 18, 20266-KReport of a foreign private issuer· period Aug 17, 2026Document · Index
Aug 10, 20266-KReport of a foreign private issuer· period Aug 10, 2026Document · Index
Aug 10, 20266-KReport of a foreign private issuer· period Aug 6, 2026Document · Index
Aug 4, 20266-KReport of a foreign private issuer· period Aug 4, 2026Document · Index
Aug 4, 20266-KReport of a foreign private issuer· period Aug 4, 2026Document · Index
Aug 4, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 31, 20266-KReport of a foreign private issuer· period Jul 31, 2026Document · Index
Jul 27, 20266-KReport of a foreign private issuer· period Jul 27, 2026Document · Index
Jul 21, 20266-KReport of a foreign private issuer· period Jul 20, 2026Document · Index
Jul 13, 20266-KReport of a foreign private issuer· period Jul 13, 2026Document · Index
Jul 6, 20266-KReport of a foreign private issuer· period Jul 6, 2026Document · Index
Jun 29, 20266-KReport of a foreign private issuer· period Jun 29, 2026Document · Index
Jun 24, 20266-KReport of a foreign private issuer· period Jun 22, 2026Document · Index
Jun 22, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 22, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 22, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jun 15, 20266-KReport of a foreign private issuer· period Jun 15, 2026Document · Index
Jun 8, 20266-KReport of a foreign private issuer· period Jun 8, 2026Document · Index
Jun 1, 20266-KReport of a foreign private issuer· period Jun 1, 2026Document · Index
May 27, 20266-KReport of a foreign private issuer· period May 26, 2026Document · Index
May 22, 20266-KReport of a foreign private issuer· period May 22, 2026Document · Index
May 22, 20266-KReport of a foreign private issuer· period May 22, 2026Document · Index
May 22, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 18, 20266-KReport of a foreign private issuer· period May 18, 2026Document · Index
May 13, 20266-KReport of a foreign private issuer· period May 12, 2026Document · Index
May 6, 20266-KReport of a foreign private issuer· period Mar 31, 2026Document · Index
May 5, 20266-KReport of a foreign private issuer· period May 5, 2026Document · Index
Apr 27, 20266-KReport of a foreign private issuer· period Apr 27, 2026Document · Index

Insider filing activity

0 Form 4 filings appear in NOVO NORDISK A S’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000353278 and XBRL company facts. NOVO NORDISK A S on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.